When a clinical trial opens, finding the right patients is often the slowest step, delaying potential treatments for months or years. Leapcure, a San Francisco-based startup founded in 2015, is betting that the answer lies not in more advertising, but in the trusted networks of patient advocacy groups [Leapcure, Unknown].
The Advocacy-First Wedge
Leapcure's core premise is humane in its simplicity: connect pharmaceutical and medical device sponsors directly to the communities that care most deeply about a condition. The platform supports patient recruitment, engagement, retention, and analytics, using a study's specific criteria to match potential participants [Craft, Unknown]. But its wedge is the relationship with advocacy groups, which the company says now number over 12,000 across 42 countries [Leapcure, Unknown]. For sponsors, this offers a path to engaged, pre-screened populations; for advocacy groups, it's a tool to actively shape the research that affects their members.
Bolstering the Bench with Honeybee
In August 2024, Leapcure moved to strengthen its hand with the acquisition of Honeybee Trials, a University of Toronto startup that connects research teams with patients [Accesswire, Aug 2024]. The deal expands Leapcure's capabilities and collaborations with research sites, biotech firms, and private clinical trial locations [Leapcure Blog, Unknown]. For CEO Zachary Gobst, who was motivated to launch the company after a family health scare, the acquisition is part of an evolution from a pure technology startup into what he calls a purpose-driven clinical research services company [Apple Podcasts, June 2025].
A Lean Financial Foundation
Leapcure's publicly disclosed funding is modest, especially for a company operating in a capital-intensive sector. The table below outlines its known financing history.
| Round | Date | Amount | Lead Investor |
|---|---|---|---|
| Seed | 2015 | $125,000 | Unknown [Startup Fundraising, Aug 2026] |
| Seed | August 2016 | Undisclosed | 500 Global [Tracxn, Unknown] |
This financial footprint places the company's growth largely on the backs of its early claims and operational grit. Historical pitch materials from 2015 cited revenue from four of the top 20 global pharma companies and an ability to recruit 75 patients in 60 days [Startup Fundraising, Aug 2026]. While unverified, these metrics framed an early ambition to disrupt a market where patient recruitment can consume nearly a third of a trial's timeline.
Navigating a Crowded Field
The clinical trial recruitment space is fragmented, with several approaches vying for sponsor budgets. Leapcure's advocacy-centric model faces distinct competitive pressures.
- Algorithmic matchers. Competitors like Antidote and Deep 6 AI focus on mining electronic health records and digital footprints to algorithmically identify eligible patients, prioritizing data scale over community trust.
- Site-centric platforms. Companies such as Trialbee and Leal Health build tools that integrate directly with clinical research sites, aiming to streamline the site's own recruitment workflows.
- Direct-to-patient services. Startups like SubjectWell and Outcomes4Me attempt to reach patients directly through digital advertising and consumer apps, bypassing both advocacy groups and care providers.
Leapcure's differentiation rests on the quality and trust inherent in its network, a factor that is harder to quantify but potentially more durable if it translates to higher participant retention and satisfaction.
The Burden of Proof
For all its narrative appeal, Leapcure operates in a field where evidence is currency. The company's most impressive claims,the 12,000 advocacy groups and early pharma revenue,are self-reported and lack independent, peer-reviewed validation. In an industry regulated by the FDA and EMA, sponsors increasingly demand proven, data-driven recruitment strategies with clear return on investment. The small seed funding also raises questions about the company's runway to scale against better-capitalized rivals.
The company's most plausible counter is the Honeybee acquisition and its continued engagement with industry dialogue. Gobst has recently discussed patient recruitment challenges and the impact of AI on podcasts, suggesting an ongoing effort to stay relevant in a shifting landscape [Note to File Podcast, 2026]. The expansion into medical device trials, as noted by CB Insights, also opens a parallel market with similar recruitment pain points [CB Insights, Unknown].
The Patient's Wait
The ultimate test for any recruitment platform is felt not in a sponsor's boardroom, but in a clinic. For a patient with metastatic breast cancer or a child with a rare genetic disorder, the current standard of care for finding a trial is often a frustrating blend of reliance on an overburdened oncologist, desperate online searches, and sheer chance. This inefficient system leaves potentially life-extending treatments idle and patients in limbo. Leapcure's bet is that by empowering the advocacy groups these patients already trust, it can make the path from diagnosis to trial participation less a matter of luck and more a function of design.
Sources
- [Leapcure, Unknown] About Leapcure | https://leapcure.com/en/about
- [Craft, Unknown] Leapcure Company Profile | https://craft.co/leapcure
- [Accesswire, Aug 2024] Leapcure Acquires Honeybee Trials | https://www.accesswire.com/
- [Leapcure Blog, Unknown] Leapcure Acquires Honeybee Trials | https://blog.leapcure.com/leapcure-acquires-honeybee-trials-expanding-patient-engagement-and-research-site-solutions-for-clinical-trials/
- [Apple Podcasts, June 2025] Zach Gobst: CEO of Leapcure | https://podcasts.apple.com/us/podcast/zach-gobst-ceo-of-leapcure/id1798984533?i=1000715122762
- [Startup Fundraising, Aug 2026] Leapcure Pitch Deck Breakdown | https://startupfundraising.com/library/articles/leapcure-pitch-deck-teardown
- [Tracxn, Unknown] Leapcure Overview | https://tracxn.com/d/companies/leapcure/__Wsja0dXyCHee6awjG91aNXt1S2Caa-DHMitvlbN8byY
- [Note to File Podcast, 2026] Patient Recruitment with Zach Gobst | https://notetofilepodcast.libsyn.com/patient-recruitment-site-struggles-and-the-realities-of-podcasting-with-zach-gobst
- [CB Insights, Unknown] Leapcure Company Profile | https://www.cbinsights.com/company/leapcure